Theriva Biologics, Inc. (TOVX)
NYSE · Healthcare
Theriva Biologics, Inc. Revenue 2010–2011
Theriva Biologics, Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Theriva Biologics, Inc. revenue for the quarter ending March 31, 2026 was 300000.
- Theriva Biologics, Inc. revenue for the twelve months ending March 31, 2026 was 1.2 M.
- Theriva Biologics, Inc. annual revenue for 2011 was 0, a 100.00% decrease from 2010.
- Theriva Biologics, Inc. annual revenue for 2010 was 2.6 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Theriva Biologics, Inc. (TOVX) — Frequently Asked Questions
Theriva Biologics, Inc. (TOVX) is a publicly traded US company. It has a market capitalization of $8M. Explore TOVX's stock price, financial statements, earnings history, margins and key ratios below.
What is Theriva Biologics, Inc.'s market cap?
Theriva Biologics, Inc. (TOVX) has a market capitalization of $8M.
What is the TOVX stock price?
TOVX trades at $0.24 (+1.46% on the day).
Is TOVX profitable?
In fiscal 2011, Theriva Biologics, Inc. reported net income of -$8M.